E
Botanix Pharmaceuticals Limited
BXPHF
$0.25
$0.000.00%
E
Sell
8/30/2024Downgrade
Botanix Pharmaceuticals Limited (BXPHF) was downgraded to E+ from D- on 8/30/2024 due to a decline in the valuation index.
Botanix Pharmaceuticals Limited (BXPHF) was downgraded to E+ from D- on 8/30/2024 due to a decline in the valuation index.
D
Sell
8/15/2024Upgraded
Botanix Pharmaceuticals Limited (BXPHF) was upgraded to D- from E+ on 8/15/2024 due to a noticeable increase in the total return index and valuation index.
Botanix Pharmaceuticals Limited (BXPHF) was upgraded to D- from E+ on 8/15/2024 due to a noticeable increase in the total return index and valuation index.
E
Sell
5/29/2024Downgrade
Botanix Pharmaceuticals Limited (BXPHF) was downgraded to E+ from D- on 5/29/2024 due to a decline in the valuation index, total return index and growth index.
Botanix Pharmaceuticals Limited (BXPHF) was downgraded to E+ from D- on 5/29/2024 due to a decline in the valuation index, total return index and growth index.
D
Sell
4/25/2024Upgraded
Botanix Pharmaceuticals Limited (BXPHF) was upgraded to D- from E+ on 4/25/2024 due to an increase in the valuation index and solvency index.
Botanix Pharmaceuticals Limited (BXPHF) was upgraded to D- from E+ on 4/25/2024 due to an increase in the valuation index and solvency index.
E
Sell
2/13/2024Downgrade
Botanix Pharmaceuticals Limited (BXPHF) was downgraded to E+ from D- on 2/13/2024 due to a large decline in the total return index, valuation index and growth index.
Botanix Pharmaceuticals Limited (BXPHF) was downgraded to E+ from D- on 2/13/2024 due to a large decline in the total return index, valuation index and growth index.
D
Sell
1/19/2024Upgraded
Botanix Pharmaceuticals Limited (BXPHF) was upgraded to D- from E+ on 1/19/2024 due to a significant increase in the total return index, growth index and valuation index. EBIT increased 2.27% from -$1.54M to -$1.51M, total revenue increased 2.26% from -$97.4 to -$95.2, and operating cash flow increased 2.26% from -$2.17M to -$2.12M.
Botanix Pharmaceuticals Limited (BXPHF) was upgraded to D- from E+ on 1/19/2024 due to a significant increase in the total return index, growth index and valuation index. EBIT increased 2.27% from -$1.54M to -$1.51M, total revenue increased 2.26% from -$97.4 to -$95.2, and operating cash flow increased 2.26% from -$2.17M to -$2.12M.
E
Sell
3/28/2023Downgrade
Botanix Pharmaceuticals Limited (BXPHF) was downgraded to E+ from D- on 3/28/2023 due to a decline in the valuation index.
Botanix Pharmaceuticals Limited (BXPHF) was downgraded to E+ from D- on 3/28/2023 due to a decline in the valuation index.
D
Sell
3/21/2023Downgrade
Botanix Pharmaceuticals Limited (BXPHF) was downgraded to D- from D on 3/21/2023 due to a decline in the valuation index.
Botanix Pharmaceuticals Limited (BXPHF) was downgraded to D- from D on 3/21/2023 due to a decline in the valuation index.
D
Sell
3/6/2023Upgraded
Botanix Pharmaceuticals Limited (BXPHF) was upgraded to D from D- on 3/6/2023 due to a large increase in the solvency index, growth index and valuation index. Operating cash flow increased 3.83% from -$1.96M to -$1.88M, and EBIT increased 3.83% from -$1.58M to -$1.52M.
Botanix Pharmaceuticals Limited (BXPHF) was upgraded to D from D- on 3/6/2023 due to a large increase in the solvency index, growth index and valuation index. Operating cash flow increased 3.83% from -$1.96M to -$1.88M, and EBIT increased 3.83% from -$1.58M to -$1.52M.
D
Sell
2/7/2023Downgrade
Botanix Pharmaceuticals Limited (BXPHF) was downgraded to D- from D on 2/7/2023 due to a decline in the total return index and volatility index.
Botanix Pharmaceuticals Limited (BXPHF) was downgraded to D- from D on 2/7/2023 due to a decline in the total return index and volatility index.
D
Sell
12/23/2022Upgraded
Botanix Pharmaceuticals Limited (BXPHF) was upgraded to D from D- on 12/23/2022 due to an increase in the total return index, volatility index and valuation index.
Botanix Pharmaceuticals Limited (BXPHF) was upgraded to D from D- on 12/23/2022 due to an increase in the total return index, volatility index and valuation index.
D
Sell
12/1/2022Downgrade
Botanix Pharmaceuticals Limited (BXPHF) was downgraded to D- from D on 12/1/2022 due to a noticeable decline in the growth index, total return index and solvency index. Debt to equity increased from 0.01 to 0.02, and total revenue declined 1.38% from $998 to $984.2.
Botanix Pharmaceuticals Limited (BXPHF) was downgraded to D- from D on 12/1/2022 due to a noticeable decline in the growth index, total return index and solvency index. Debt to equity increased from 0.01 to 0.02, and total revenue declined 1.38% from $998 to $984.2.
D
Sell
5/16/2022Upgraded
Botanix Pharmaceuticals Limited (BXPHF) was upgraded to D from E+ on 05/16/2022.
Botanix Pharmaceuticals Limited (BXPHF) was upgraded to D from E+ on 05/16/2022.
E
Sell
5/13/2022Downgrade
Botanix Pharmaceuticals Limited (BXPHF) was downgraded to E+ from D on 5/13/2022 due to a decline in the total return index.
Botanix Pharmaceuticals Limited (BXPHF) was downgraded to E+ from D on 5/13/2022 due to a decline in the total return index.
D
Sell
5/4/2022Upgraded
Botanix Pharmaceuticals Limited (BXPHF) was upgraded to D from E+ on 5/4/2022 due to an increase in the valuation index.
Botanix Pharmaceuticals Limited (BXPHF) was upgraded to D from E+ on 5/4/2022 due to an increase in the valuation index.
E
Sell
5/1/2022Downgrade
Botanix Pharmaceuticals Limited (BXPHF) was downgraded to E+ from D on 05/01/2022.
Botanix Pharmaceuticals Limited (BXPHF) was downgraded to E+ from D on 05/01/2022.
D
Sell
4/21/2022Upgraded
Botanix Pharmaceuticals Limited (BXPHF) was upgraded to D from E+ on 4/21/2022 due to an increase in the total return index and volatility index.
Botanix Pharmaceuticals Limited (BXPHF) was upgraded to D from E+ on 4/21/2022 due to an increase in the total return index and volatility index.
E
Sell
4/20/2022Downgrade
Botanix Pharmaceuticals Limited (BXPHF) was downgraded to E+ from D on 4/20/2022 due to a major decline in the solvency index, growth index and valuation index.
Botanix Pharmaceuticals Limited (BXPHF) was downgraded to E+ from D on 4/20/2022 due to a major decline in the solvency index, growth index and valuation index.
D
Sell
11/23/2021Upgraded
Botanix Pharmaceuticals Limited (BXPHF) was upgraded to D from D- on 11/23/2021.
Botanix Pharmaceuticals Limited (BXPHF) was upgraded to D from D- on 11/23/2021.
D
Sell
11/8/2021Downgrade
Botanix Pharmaceuticals Limited (BXPHF) was downgraded to D- from D on 11/8/2021 due to a decline in the valuation index.
Botanix Pharmaceuticals Limited (BXPHF) was downgraded to D- from D on 11/8/2021 due to a decline in the valuation index.
D
Sell
10/1/2020Upgraded
Botanix Pharmaceuticals Limited (BXPHF) was upgraded to D from D- on 10/1/2020 due to an increase in the volatility index and total return index.
Botanix Pharmaceuticals Limited (BXPHF) was upgraded to D from D- on 10/1/2020 due to an increase in the volatility index and total return index.
D
Sell
6/2/2020Upgraded
Botanix Pharmaceuticals Limited (BXPHF) was upgraded to D- from E on 6/2/2020 due to an increase in the growth index, volatility index and valuation index.
Botanix Pharmaceuticals Limited (BXPHF) was upgraded to D- from E on 6/2/2020 due to an increase in the growth index, volatility index and valuation index.
E
Sell
3/2/2020Upgraded
Botanix Pharmaceuticals Limited (BXPHF) was upgraded to E from E- on 3/2/2020 due to a substantial increase in the solvency index, valuation index and efficiency index. Total capital increased 4.17% from $22.65M to $23.59M, and net income increased 0.3% from -$2.4M to -$2.39M.
Botanix Pharmaceuticals Limited (BXPHF) was upgraded to E from E- on 3/2/2020 due to a substantial increase in the solvency index, valuation index and efficiency index. Total capital increased 4.17% from $22.65M to $23.59M, and net income increased 0.3% from -$2.4M to -$2.39M.
E
Sell
12/2/2019None
Botanix Pharmaceuticals Limited (BXPHF) was downgraded to E- from U on 12/02/2019.
Botanix Pharmaceuticals Limited (BXPHF) was downgraded to E- from U on 12/02/2019.
OTC PK
04/01/2025 3:38PM Eastern
Quotes delayed
